CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $782,929 | -9.2% | 26,576 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $862,342 | -4.4% | 26,436 | +3.1% | 0.00% | 0.0% |
| Q1 2023 | $902,131 | -23.2% | 25,636 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $1,174,642 | -12.3% | 25,636 | -7.3% | 0.00% | 0.0% |
| Q3 2022 | $1,340,000 | +23.3% | 27,656 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,087,000 | +6.8% | 27,656 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $1,018,000 | -19.3% | 27,656 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,261,000 | +27.6% | 27,656 | +0.1% | 0.00% | 0.0% |
| Q3 2021 | $988,000 | +80.6% | 27,631 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $547,000 | -10.0% | 27,631 | +5.7% | 0.00% | 0.0% |
| Q1 2021 | $608,000 | +11.2% | 26,129 | -0.7% | 0.00% | 0.0% |
| Q4 2020 | $547,000 | -4.0% | 26,319 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $570,000 | -7.8% | 26,319 | +0.5% | 0.00% | -50.0% |
| Q2 2020 | $618,000 | +100.0% | 26,199 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $309,000 | +11.2% | 26,199 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $278,000 | -6.7% | 26,199 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $298,000 | +1.0% | 26,199 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $295,000 | +43.2% | 26,199 | +2.7% | 0.00% | 0.0% |
| Q1 2019 | $206,000 | +28.0% | 25,519 | 0.0% | 0.00% | – |
| Q4 2018 | $161,000 | -35.9% | 25,519 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $251,000 | +18.4% | 25,519 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $212,000 | +15.2% | 25,519 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $184,000 | -11.5% | 25,519 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $208,000 | -43.8% | 25,519 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $370,000 | +19.7% | 25,519 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $309,000 | +60.9% | 25,519 | +70.8% | 0.00% | 0.0% |
| Q1 2017 | $192,000 | +6.1% | 14,938 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $181,000 | +32.1% | 14,938 | 0.0% | 0.00% | – |
| Q3 2016 | $137,000 | -2.1% | 14,938 | +1.1% | 0.00% | – |
| Q2 2016 | $140,000 | +86.7% | 14,778 | +38.4% | 0.00% | – |
| Q1 2016 | $75,000 | -33.0% | 10,675 | 0.0% | 0.00% | – |
| Q4 2015 | $112,000 | +57.7% | 10,675 | +0.5% | 0.00% | – |
| Q3 2015 | $71,000 | 0.0% | 10,627 | 0.0% | 0.00% | – |
| Q2 2015 | $71,000 | -1.4% | 10,627 | 0.0% | 0.00% | – |
| Q1 2015 | $72,000 | -14.3% | 10,627 | +1.9% | 0.00% | – |
| Q4 2014 | $84,000 | +127.0% | 10,427 | 0.0% | 0.00% | – |
| Q3 2014 | $37,000 | -26.0% | 10,427 | 0.0% | 0.00% | – |
| Q2 2014 | $50,000 | – | 10,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |